Treatment with controlled-release lovastatin decreases serum concentrations of human β-amyloid (Aβ) peptide

Abstract

The deposition of β-amyloid (Aβ) in neuronal plaques is believed to be crucial for the initiation and progression of Alzheimer's disease (AD). Studie